Filing Details
- Accession Number:
- 0001570562-19-000095
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-04 19:52:55
- Reporting Period:
- 2019-06-03
- Accepted Time:
- 2019-06-04 19:52:55
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1570562 | Evolus Inc. | EOLS | Pharmaceutical Preparations (2834) | 461385614 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1730123 | Vikram Malik | 520 Newport Center Dr. Suite 1200 Newport Beach CA 92660 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-06-03 | 1,298,701 | $19.25 | 1,298,701 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
Footnotes
- The acquisition of the shares of common stock referenced in this Form 4 was conducted in a private transaction between ALPHAEON Corporation ("ALPHAEON") and Strathspey Crown Holdings Group, LLC ("SCH"). SCH is the majority shareholder of ALPHAEON. The shares of common stock received by SCH are deemed "restricted securities" under Rule 144 promulgated under the Securities Act of 1933, as amended.
- The reported securities are directly owned by SCH and may be deemed beneficially owned by the Reporting Person as a Managing Partner of SCH. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose